Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1493 clinical trials
Featured trial
BRAIN-SILK SIMS.

This study is looking for people who are over 75, are in hospice care, and have Alzheimer’s (or normal cognition, for a comparison). The study is developing a new brain scan for Alzheimer’s.

  • 0 views
  • 15 Sep, 2020
  • 1 location
Featured trial
Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

dementia
memantine
acetylcholinesterase
demented
memory impairment
  • 881 views
  • 23 Nov, 2020
  • 3 locations
Featured trial
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, 52-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF SIMUFILAM 100 MG TABLETS IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE

Simufilam is an experimental treatment, meaning that it has not yet been approved by the United States (US) Food and Drug Administration (FDA). In this study, the study medicine will be compared to a placebo. A placebo is a pill that looks exactly like the study medicine but does not …

  • 2 views
  • 25 Mar, 2022
  • 1 location
Featured trial
  • 34 views
  • 08 Dec, 2020
  • 1 location
Featured trial
Apathy and Reward Systems in Alzheimer’s Disease

This study is looking for people over the age of 65 who have either early stage Alzheimer’s/mild cognitive impairment or depression. The study is interested in examining cognition and brain characteristics, and their relationship with Alzheimer’s and depression.

cognitive impairment
psychiatric disorder
mild cognitive impairment
depressed mood
  • 34 views
  • 24 May, 2022
  • 1 location
Featured trial
A PHASE III, MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GANTENERUMAB IN PARTICIPANTS AT RISK FOR OR AT THE EARLIEST STAGES OF ALZHEIMER’S DISEASE

This study is designed to evaluate the efficacy and safety of Gantenerumab in participants at risk for or at the earliest stages of Alzheimer’s Disease (AD

Accepts healthy volunteers
  • 4 views
  • 24 Jun, 2022
  • 1 location
Featured trial
A PATIENT- AND INVESTIGATOR-BLIND, PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BEPRANEMAB (UCB0107) IN STUDY PARTICIPANTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE (AD), FOLLOWED BY AN OPENLABEL EXTENSION PERIOD

Bepranemab (UCB0107) is being developed with the aim of blocking or reducing the cell-to-cell spread of tau pathology in patients with tau-mediated diseases, such as AD. To date, single

  • 14 views
  • 24 Jun, 2022
  • 1 location
Featured trial
The Health and Aging Brain Study: Health Disparities

Alzheimer’s disease is the most common cause of memory problems as we age. However, many things can impact our thinking over time. At HSC, we are working to find new and better ways to treat and prevent memory loss during the aging process. The research we do today aims to …

Accepts healthy volunteers
alzheimer's disease
  • 20 views
  • 14 Jun, 2022
  • 1 location
Featured trial
Mild Dementia/Alzheimer's Disease

Mild Dementia/Alzheimer's Disease

  • 474 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Alzheimer's Disease

As we age, brain changes can result in memory concerns. There are, however, some cognitive changes that are not part of the normal aging process, but may actually be the onset of Alzheimer’s disease. Alzheimer’s disease is a degenerative disorder that destroys nerve cells (neurons) in the brain. As these …

alzheimer's disease
  • 23 views
  • 30 Jul, 2021
  • 1 location